| Status: | Phase 2 |
| Entry Type: | Oligonucleotide |
| Molecule Category: | UNKNOWN |
Indications
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Carcinoma, Non-Small-Cell Lung; Lung Neoplasms | Phase 2 | ClinicalTrials |
| Prostatic Neoplasms | Phase 2 | ClinicalTrials |
| Pancreatic Neoplasms | Phase 2 | ClinicalTrials |
| Prostatic Neoplasms | Phase 2 | ClinicalTrials |
| Carcinoma; Carcinoma, Transitional Cell; Urinary Bladder Neoplasms | Phase 2 | ClinicalTrials |
| Urinary Bladder Neoplasms | Phase 1 | ClinicalTrials |
CONTENTS